Pavlina Spiliopoulou

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
For decades, effective cancer gene therapy has been a tantalising prospect; for a therapeutic modality potentially able to elicit highly effective and selective responses, definitive efficacy outcomes have often seemed out of reach. However, steady progress in vector development and accumulated experience from previous clinical studies has finally led the(More)
  • 1